Xiaojie Tan

Qingdao University

Papers

3

Total Citations

38

H-Index

3

About

Xiaojie Tan is a leading surgical oncologist whose research focuses on optimizing outcomes for patients with gastric cancer and adenocarcinoma of the esophagogastric junction (AEG). Her work bridges the gap between perioperative care and advanced surgical techniques. Notably, she led a landmark randomized controlled trial demonstrating that drinking Chinese green tea postoperatively can safely stimulate bowel recovery and improve short-term outcomes after gastric cancer surgery, a finding with 25 citations that offers a simple, cost-effective intervention to reduce postoperative ileus. Tan is also at the forefront of robotic surgery research. She has conducted detailed analyses identifying and categorizing technical errors and hazard zones in robotic versus laparoscopic total gastrectomy, providing a safety roadmap for surgeons. Her comparative studies on robotic and laparoscopic-assisted surgery for Siewert type II AEG have clarified the benefits of robotic approaches for lymph node dissection and short-term recovery. With a growing citation impact, Tan’s contributions are shaping evidence-based protocols for both the technical execution and postoperative management of complex gastric cancer surgeries, making her a pivotal figure in modern surgical oncology.

Research Focus

Key Achievements

3
H-Index
3
Papers
38
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Impact of drinking Chinese green tea on postoperative short outcomes for gastric cancer: a randomized controlled trial
25 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 27
🏛 Institutions: Qingdao University

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago